The second cluster, shown in the far-right part of Figure S7, is represented by eleven lincRNAs (LINC00907, LINC01254, LINC01387, LINC01415, LINC01416, LINC01443, LINC01477, LINC01478, LINC01538, LINC01539, and LINC01544), which are characterized by hallmarks ‘D’ (copy number variations), ‘G’ (cancer-type-specific differential expression), ‘M’ (predicted relations in cancer-associated pathways), ‘O’ (potential prognostic value), and ‘Q’ (gene expression signatures for drug prediction). This evidence concerns the gene LINC01478 and cancer.